JHS Svendgaard Q1 FY27 Results: Revenue Rs 30 Cr, PAT Rs 1 Cr and Key Highlights

JHS Svendgaard Q1 FY27 results were announced on August 11, 2026, reporting a net profit (PAT) of Rs 1 crore, up 3.34% from Rs 1 crore in Q1 FY26. Revenue from operations grew 29.53% year on year to Rs 30 crore from Rs 23 crore in Q1 FY26. The JHS Svendgaard Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.

Click Here – Get Free Investment Predictions

JHS Svendgaard Q1 FY27 Financial Highlights

The table below presents key financial metrics from the JHS Svendgaard Q1 FY27 results against the corresponding quarter of the prior year.

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Revenue from Operations (Rs Cr)	Rs 30 Cr	Rs 23 Cr	+29.53%
Gross Profit (Rs Cr)	Rs 0.26 Cr	Rs -0.21 Cr	+219.36%
Net Profit / (Loss) – PAT (Rs Cr)	Rs 1 Cr	Rs 1 Cr	+3.34%

JHS Svendgaard Q1 FY27 Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

The JHS Svendgaard Q1 FY27 results show revenue growth of 29.53% year on year to Rs 30 crore. Gross profit stood at Rs 0.26 crore against Rs -0.21 crore in Q1 FY26.

Net profit in the June 2026 quarter stood at Rs 1 crore, a 3.34% rise year on year. Investors should verify these figures against official BSE and NSE filings.

Key Business Factors in JHS Svendgaard Q1 FY27

1. Revenue Growth Drove Top-Line Expansion

Revenue grew 29.53% yoy to rs 30 crore from rs 23 crore. Demand improvement in the Healthcare and Oral Care segment contributed to the positive top-line performance in the June 2026 quarter.

2. Gross Profit Momentum Supported Operating Margins

Gross profit in the June 2026 quarter stood at Rs 0.26 crore from Rs -0.21 crore in Q1 FY26, a 219.36% improvement. Better pricing and cost control contributed to the operational improvement.

3. Net Profit Improvement Reflects Stronger Profitability

PAT came in at Rs 1 crore, up 3.34% from Rs 1 crore in Q1 FY26. This reflects the company's improving earnings trajectory in the Healthcare and Oral Care space.

Dividend Details

No dividend has been declared alongside the JHS Svendgaard Q1 FY27 results for the quarter ended June 2026. Investors may track any future dividend announcements on BSE and NSE.

JHS Svendgaard FY27 Outlook After Q1 Results

JHS Svendgaard Q1 FY27 results set a broadly positive tone for FY27. Revenue grew 29.53% yoy to rs 30 crore from rs 23 crore and a net profit (PAT) of Rs 1 crore provide a foundation for sustained improvement. Investors tracking JHS Svendgaard Q1 results should monitor demand conditions in Healthcare and Oral Care, input cost trends, and any expansion plans shaping FY27 earnings.

JHS Svendgaard Stock Performance

Download the Univest iOS App or Univest Android App to track JHS Svendgaard live share price and upcoming quarterly results.

JHS Svendgaard share price stood at Rs 9.01 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Healthcare and Oral Care company's financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before any investment decision.

Key Risks to Watch After JHS Svendgaard Q1 FY27 Results

1. Sector-Specific Demand Headwinds

A slowdown in the Healthcare and Oral Care sector could weigh on JHS Svendgaard revenue and profitability beyond what the June 2026 quarter currently indicates.

2. Input Cost and Margin Pressure

Rising raw material or operational costs could compress gross margins and limit net profit improvement in subsequent quarters of FY27.

3. Macroeconomic and Regulatory Uncertainty

Inflation, interest rate movements, and regulatory shifts remain key risks to the JHS Svendgaard earnings trajectory through FY27.

Conclusion

JHS Svendgaard Q1 FY27 results report revenue of Rs 30 crore and a net profit (PAT) of Rs 1 crore, up 3.34% from Rs 1 crore in Q1 FY26. The June 2026 quarterly performance reflects the company's position in the Healthcare and Oral Care space. Investors should study the complete financials on BSE and NSE and consult a SEBI-registered advisor before any investment decision.

Frequently Asked Questions on JHS Svendgaard Q1 FY27 Results

When were the JHS Svendgaard Q1 FY27 results announced?

Ans. The June 2026 quarterly results for JHS Svendgaard were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.

What is the PAT in the JHS Svendgaard Q1 FY27 results?

Ans. PAT (net profit) stood at Rs 1 crore in the June 2026 quarter, up 3.34% from Rs 1 crore in Q1 FY26.

What was the revenue in the JHS Svendgaard Q1 FY27 results?

Ans. Revenue for the June 2026 quarter rose 29.53% year on year to Rs 30 crore from Rs 23 crore in Q1 FY26.

Did JHS Svendgaard announce any dividend with the Q1 FY27 results?

Ans. No dividend has been declared alongside the June 2026 quarterly results of JHS Svendgaard. Investors may track future dividend announcements on the BSE and NSE portals.

What is the JHS Svendgaard FY27 outlook after Q1 results?

Ans. The June 2026 quarterly data signals a positive start to FY27 for JHS Svendgaard. Revenue trends, margin performance, and Healthcare and Oral Care sector demand will be the key factors to watch through the rest of the financial year.

Is JHS Svendgaard a good buy after Q1 FY27 results?

Ans. The Q1 FY27 quarterly performance of JHS Svendgaard reflects improving trends. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any investment decision.